三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

US company partners with Chinese firm to tackle rare disease

Xinhua | Updated: 2017-09-27 09:13
Share
Share - WeChat

SHANGHAI — Staff with US company Amicus Therapeutics regularly travel to Shanghai to work out how to develop a new drug to treat Pompe disease, a rare muscle disorder.

John Crowley, chief executive of the company, led the recent trip to its Chinese partner WuXi Biologics, based in Shanghai.

Crowley said the new drug was expected to reduce the side effects of existing enzyme replacement therapy.

The disorder prevents the human body from making enough of an enzyme used by heart and muscle cells to convert a form of sugar called glycogen into energy. When glycogen builds up in these cells it can lead to swelling of the heart, disability and early death.

Crowley has led a personal struggle to save his daughter and son, who are afflicted with Pompe disease.

Crowley said his company chose WuXi Biologics as its contract manufacturer, even though some company board members questioned the decision, doubting such high-quality drugs could be made by a Chinese firm.

Currently, the drug is in stage two of clinical trials, and around 20 patients are being tested with the drug in the United States.

By the middle of next year, it is expected to enter stage three, and be applied to more patients for tests, Crowley said.

Chinese patients are expected to be included in the trials, he said. Gao Ru, founder of a Chinese Pompe patient association, said the cooperation would benefit Chinese patients. She estimated there are about 35,000 Pompe patients in China.

Gao said she managed to contact about 100 of them, 80 percent of whom were adults, and 20 percent babies.

For an adult patient, the annual medical cost is around 3 million yuan (about $460,000).

"I hope the cost for the prescription can be reduced," she said.

Crowley helped founded Novazyme, a company working on Pompe disease treatment. The company was was acquired by Genzyme in 2011. Now Paris-based Sanofi SA owns the drugs. He later founded Amicus Therapeutics to develop therapy for rare disease including Pompe.

"If you compare ordinary drugs to a bicycle, bio-medicine is like a plane. It is very difficult to make," said Chen Zhisheng, CEO of WuXi Biologics.

"The new generation drugs to treat Pompe diseases needs to be very accurate in dealing with the disorder. Both our companies will be committed to the development of the drugs until they are put on the market and bring benefits to patients," Chen said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 在线免费黄色网址 | 香蕉视频首页 | 成年视频xxxxx免费播放软件 | 国产精品yjizz视频网一二区 | 尤物tv | 日韩天天摸天天澡天天爽视频 | 免费成人黄色 | 日韩欧美一级毛片精品6 | 午夜精品一区二区三区在线视 | 三级毛片在线免费观看 | 182tv成人午夜在线观看 | 国产亚洲精品久久久久久久久激情 | 国产精品免费视频一区二区三区 | 91国内在线国内在线播放 | 国产精品91在线播放 | 欧美特欧美特级一片 | 91精品福利手机国产在线 | 欧美精品久久久久久久免费观看 | 2020狠狠操 | 欧美人在线一区二区三区 | 国产一级二级三级毛片 | 久草免费网站 | 亚洲综合色婷婷六月丁香 | 男人和女人做a免费视频 | 成 人 免费观看网站 | 深夜国产 | 久久www免费人成_看片高清 | 国产成+人欧美+综合在线观看 | 永久免费看www色视频 | 在线免费国产视频 | 国产精品人成福利视频 | 一级毛片在线完整观看 | 国产精品国产三级国产专不∫ | 一级特黄国产高清毛片97看片 | 中文字幕国产在线观看 | 精品国产一区二区三区www | 亚洲综合精品一二三区在线 | 久久精品人人做人人爽 | 久在线视频 | 青青国产成人久久91网 | 欧美换爱交换乱理伦片不卡片 |